UAB Digital Repository of Documents 3 records found  Search took 0.00 seconds. 
1.
5 p, 104.3 KB Atenció Al Malalt Crític Hospitalari i Extrahospitalari [105016] / Arméstar, Fernando ; Betbesé Roig, Antoni Jordi ; Ricart Martí, Pilar ; Díaz Santos, Emilio ; Ferrer Roca, Ricard ; Universitat Autònoma de Barcelona. Facultat de Medicina
Es tracta d'una assignatura optativa lligada a la menció de Clínica Mèdica, impartida a sisè curs del Grau de Medicina. L'objectiu general és el coneixement de la fisiopatologia bàsica del malalt crític i la seva aplicació al maneig del mateix, tant a l'àmbit hospitalari com extrahospitalari.
This is an optional subject linked to the mention of Medical Clinic, taught in the sixth year of the Degree in Medicine. The general objective is the knowledge of the basic pathophysiology of the critical pati.
Se trata de una asignatura optativa ligada a la mención de Clínica Médica, impartida en sexto curso del Grado de Medicina. El objetivo general es el conocimiento de la fisiopatología básica del enfermo crítico y su aplicación al manejodel mismo, tanto en el ámbito hospitalario como extrahospitalario.

2023-24
Grau en Medicina [1192]
Grau en Medicina [1509]
3 documents
2.
14 p, 1.9 MB Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients : a randomised controlled trial / Chastre, Jean (Service de Médecine Intensive Réanimation. Institut de Cardiologie. Groupe Hospitalier Pitié-Salpêtrière. Assistance Publique-Hôpitaux de Paris. Sorbonne University) ; François, Bruno (Réanimation Polyvalente and Inserm CIC 1435 & UMR 1092. CHU) ; Bourgeois, Marc (AZ Sint-Jan Brugge-Oostende AV) ; Komnos, Apostolos (General Hospital of Larissa) ; Ferrer, Ricard (Hospital Universitari Vall d'Hebron) ; Rahav, Galia (Chaim Sheba Medical Center. Sackler School of Medicine. Tel Aviv University) ; De Schryver, Nicolas (Clinique Saint-Pierre) ; Lepape, Alain (Hospices Civils de Lyon Hôpital Lyon Sud) ; Koksal, Iftihar (Faculty of Medicine. Trabzon and Acibadem University Faculty of Medicine. Karadeniz Technical University) ; Luyt, Charles-Edouard (Service de Médecine Intensive Réanimation. Institut de Cardiologie. Groupe Hospitalier Pitié-Salpêtrière. Assistance Publique-Hôpitaux de Paris. Sorbonne University) ; Sánchez-García, Miguel (Hospital Clínico San Carlos. Unidad de Cuidados Intensivos) ; Torres, Antoni (Hospital Clínic i Provincial de Barcelona. Servei de Pneumologia) ; Eggimann, Philippe (Department of Locomotor Apparatus. Centre Hospitalier Universitaire Vaudois CHUV) ; Koulenti, Despoina (2nd Critical Care Department. Attikon University Hospital. National and Kapodistrian. University of Athens) ; Holland, Thomas L. (Duke Clinical Research Institute) ; Ali, Omar (Clinical Research and Development. Vaccines and Immune Therapies. BioPharmaceuticals R&D. AstraZeneca Biopharmaceuticals) ; Shoemaker, Kathryn (Respiratory and Immunology. BioPharmaceuticals R&D. AstraZeneca) ; Ren, Pin (Respiratory and Immunology. BioPharmaceuticals R&D. AstraZeneca) ; Sauser, Julien (Infection Control Program. Faculty of Medicine. Geneva University Hospitals) ; Ruzin, Alexey (Clinical Research and Development. Vaccines and Immune Therapies. BioPharmaceuticals R&D. AstraZeneca Biopharmaceuticals) ; Tabor, David E. (Clinical Research and Development. Vaccines and Immune Therapies. BioPharmaceuticals R&D. AstraZeneca Biopharmaceuticals) ; Akhgar, Ahmad (Clinical Pharmacology and Quantitative Pharmacology. Clinical Pharmacology and Safety Sciences. BioPharmaceuticals R&D. AstraZeneca) ; Wu, Yuling (Clinical Pharmacology and Quantitative Pharmacology. Clinical Pharmacology and Safety Sciences. BioPharmaceuticals R&D. AstraZeneca) ; Jiang, Yu (Clinical Pharmacology and Quantitative Pharmacology. Clinical Pharmacology and Safety Sciences. BioPharmaceuticals R&D. AstraZeneca) ; DiGiandomenico, Antonio (Clinical Research and Development. Vaccines and Immune Therapies. BioPharmaceuticals R&D. AstraZeneca Biopharmaceuticals) ; Colbert, Susan (Oncology. US SM&M. AstraZeneca) ; Vandamme, Drieke (Inserm CIC 1435. CHU) ; Coenjaerts, Frank (University Medical Center Utrecht) ; Malhotra-Kumar, Surbhi (University of Antwerp. Laboratory of Medical Microbiology) ; Timbermont, Leen (University of Antwerp. Laboratory of Medical Microbiology) ; Oliver, Antonio (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Barraud, Olivier (INSERM U1092. Centre Hospitalier Universitaire de Limoges. Université Limoges) ; Bellamy, Terramika (Clinical Research and Development. Vaccines and Immune Therapies. BioPharmaceuticals R&D. AstraZeneca Biopharmaceuticals) ; Bonten, Marc (Julius Center for Health Science and Primary Care. University Medical Center Utrecht. Utrecht University) ; Goossens, Herman (Laboratory of Medical Microbiology. Vaccine and Infectious Disease Institute. University of Antwerp) ; Reisner, Colin (DevPro Biopharma) ; Esser, Mark T. (Clinical Research and Development. Vaccines and Immune Therapies. BioPharmaceuticals R&D. AstraZeneca Biopharmaceuticals) ; Jafri, Hasan S. (Late-Stage Development. Respiratory and Immunology. BioPharmaceuticals R&D. AstraZeneca) ; Joannidis, Michael ; Klimscha, Walter ; De Waele, Elisabeth ; Devriendt, Jacques ; Huberlant, Vincent ; Depuydt, Pieter ; Van Boxstael, Sam ; Peric, Mladen ; Kopic, Jasminka ; Hanauer, Michal ; Hruby, Tomas ; Sramek, Vladimir ; Svoboda, Petr ; Vymazal, Tomas ; Novacek, Martin ; Annane, Djillali ; Mira, Jean-Paul ; Souweine, Bertrand ; Dequin, Pierre-François ; Meziani, Ferhat ; Stephan, François ; Nseir, Saad ; Gibot, Sebastien ; Schwebel, Carole ; Plantefeve, Gaetan ; Diehl, Jean-Luc ; Richard, Christian ; Lamer, Christian ; Klouche, Kada ; Jaber, Samir ; Zakynthinos, Epaminondas ; Filntisis, Georgios ; Zakynthinos, Spyros ; Koutsoukou, Antonia ; Saroglou, Georgios ; Nikolaou, Charikleia ; Vlachogianni, Glykeria ; Pnevmatikos, Ioannis ; Mandragos, Konstantinos ; Kremer, Ildiko ; Rozgonyi, Zsolt Dezso ; Marjanek, Zsuzsa ; Martin-Loeches, Ignacio ; Singer, Pierre ; Van Heerden, Vernon ; Carmeli, Yehuda ; Povoa, Pedro ; AlvarezSeoane, Antonio ; Moura, Pedro ; Gonzalez, Filipe ; Ramirez, Paula ; Torres Marti, Antonio ; Ferrer Roca, Ricard ; Oteiza, Lorena ; Escudero, Dolores ; Piacentini, Enrique ; Vera-Artazcoz, Paula (Institut d'Investigació Biomèdica Sant Pau) ; Tamayo, Luis ; Gonzalez Gallego, Miguel Angel ; Suberviola Canas, Borja ; Figueira, Iglesias ; Leon, Rafael ; Korten, Volkan ; Akova, Murat ; Wyncoll, Duncan ; Whitehouse, Tony ; Hopkins, Phil ; Sim, Malcolm ; Golan, Yoav ; Zervos, Marcus ; Vazquez, Jose ; Cherabuddi, Kartikeya ; Smulian, George ; Rouphael, Nadine ; Welker, James ; Sims, Mathew ; Van Duin, David ; McCarthy, Todd ; Polk, Christopher
Background: Ventilator-associated pneumonia caused by Pseudomonas aeruginosa (PA) in hospitalised patients is associated with high mortality. The effectiveness of the bivalent, bispecific mAb MEDI3902 (gremubamab) in preventing PA nosocomial pneumonia was assessed in PA-colonised mechanically ventilated subjects. [...]
2022 - 10.1186/s13054-022-04204-9
Critical Care, Vol. 26 Núm. 1 (december 2022) , p. 355  
3.
2.6 MB Proyecto sobrevivir después de la UCI : Estudio prospectivo multicéntrico nacional / Cano Hernández, Silvia ; Fernández Fernández, Rafael, dir. ; Ferrer Roca, Ricard, dir.
Introducció: La mortalitat després de l'alta d'UCI és un paràmetre de qualitat assistencial i eficàcia del tractament a la unitat de cures intensives. La fragilitat que presenten els pacients a l'alta condiciona un nombre més gran de complicacions i per tant un nombre més gran de reingressos. [...]
Introducción: La mortalidad tras el alta de UCI es un parámetro de calidad asistencial y eficacia del tratamiento en la unidad de cuidados intensivos. La fragilidad que presentan los pacientes al alta condiciona un mayor número de complicaciones y por lo tanto un mayor número de reingresos. [...]
Introduction: Mortality after ICU discharge is a parameter of quality of care and efficacy of treatment in the intensive care unit. The frailty that patients present at discharge determines a greater number of complications and therefore a greater number of readmissions. [...]

2022  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.